Clinical Trial Update: Effect of Policosanol as Monotherapy and Adjunctive to Statin Therapy [NA]

View source ↗

Summary

This completed clinical trial evaluated policosanol as both monotherapy and an adjunct to statin therapy for hypercholesterolemia; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Policosanol (Policosanol)

Snippet

Sponsor: James Backes, PharmD | Conditions: High Cholesterol | NA | Status: COMPLETED | Results posted: 2012-07-20